Shah Rutul R sold $251K of PGEN
Shah Rutul R (Chief Operating Officer) sold 42,924 shares of PRECIGEN, INC. (PGEN) at $5.85 ($0.25M total) on 2026-06-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The only new fact is the disclosed sale size, price, and post-transaction holdings; it does not include guidance, trial results, or regulatory updates.
Market read
Traders may monitor insider activity for sentiment, but 10b5-1 sales typically carry less informational weight than unscheduled sales.
What to watch
The filing doesn’t disclose reasons for the sale beyond the plan; without accompanying buy/sell patterns or new company events, trading impact should be limited.
Background
The article is a primary-source SEC Form 4 insider transaction disclosure for Precigen, Inc.
Ticker impact
SEC Form 4 shows COO Shah Rutul R sold 42,924 shares of Precigen at $5.85 on 2026-06-29 under a 10b5-1 plan.
Low likelihood of a sustained price move solely from this disclosure; any reaction is likely muted and short-lived.
The filing is an open-market sale by an officer, explicitly under a pre-arranged 10b5-1 plan, with no new operating, regulatory, or financial datapoints.
Market effects
Minimal; this is company-specific insider transaction with no sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
Because it’s a 10b5-1 plan, the sale may be purely mechanical rather than a bearish view on prospects.
Key entities
- issuerPRECIGEN, INC.
Subject of the Form 4 insider transaction disclosure.
- insiderShah Rutul R
Chief Operating Officer who sold shares under a 10b5-1 plan.
